Recon: Vaccine makers shift sights to boosters; Europe launches SPAC aimed at acquiring CDMOs

Recon

ReconMichael Mezher

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy